US Corporate Board Director Changes SEC Filings — March 27, 2026

27-03-2026

On March 24, 2026, William P. Rowland resigned from the Board of Directors, including all committees, and as Interim Chief Financial Officer of One World Products, Inc., citing ongoing health issues with no disagreements on operations, policies, or practices. Isiah L. Thomas, III, the Company's CEO, has assumed the CFO duties on an interim basis until a successor is appointed. The 8-K was filed on March 27, 2026, including the resignation letter as Exhibit 17.1.

• ·Resignation effective March 24, 2026 (earliest event reported).
• ·Company address: 6605 Grand Montecito Pkwy, Suite 100, Las Vegas, Nevada 89149.
• ·Commission file number: 000-56151; I.R.S. Employer Identification No.: 61-1744826.

27-03-2026

On March 26, 2026, Traeger, Inc.'s Board of Directors reviewed the 2025 annual cash incentive program and determined that performance goals were not achieved, resulting in no payments to the company's named executive officers. Despite this, the Board awarded discretionary cash bonuses of $956,250 to CEO Jeremy Andrus and $270,938 to CFO Michael Joseph (Joey) Hord for their 2025 contributions and to promote retention. No departures, elections, or appointments of directors or officers were reported.

• ·Event reported on Form 8-K filed March 27, 2026, under Item 5.02 for Compensatory Arrangements of Certain Officers

27-03-2026

Rumble Inc. announced that effective March 31, 2026, Mike Masci, formerly VP of Product Management at Intel Corporation, will succeed Brandon Alexandroff as CFO, with Alexandroff transitioning to Strategic Advisor to the CEO. CEO Chris Pavlovski highlighted Masci's expertise in AI, cloud infrastructure, and finance as ideal for scaling Rumble's platform and pursuing AI opportunities from the pending Northern Data acquisition. The announcement underscores continuity with Alexandroff's ongoing involvement.

• ·Rumble founded in 2013 and headquartered in Longboat Key, Florida.
• ·Masci previously served as Group CFO of Intel's Datacenter Network Platforms Group and holds a Finance degree from Arizona State University.

27-03-2026

On March 26, 2026, Dr. Annalisa Jenkins informed Mereo BioPharma Group plc that she will not stand for re-election as a Director at the 2026 annual general meeting of shareholders on May 14, 2026, and will serve out the remainder of her term until then. Her decision did not result from any disagreement with the Company or the Board on matters relating to operations, policies, or practices. The filing was signed by Charles Sermon, General Counsel.

• ·Event reported date: March 26, 2026
• ·Filing date: March 27, 2026
• ·Securities: American Depositary Shares (MREO) on Nasdaq, each representing five Ordinary Shares (£0.003 par value)

27-03-2026

RenovoRx, Inc. appointed Ramtin Agah, M.D., its Chief Medical Officer and Chairman of the Board, to the newly created position of Executive Chairman, effective February 27, 2026, via an offer letter dated March 24, 2026. The agreement sets Dr. Agah's annualized base salary at $450,000 (effective January 1, 2026, for at least 30 hours per week), with eligibility for a discretionary annual bonus up to 40% of base salary (first payable in 2027) and annual equity grants under the 2021 Omnibus Equity Incentive Plan. Employment is at-will, with customary confidentiality, IP, and severance provisions remaining in effect.

• ·Appointment formalized by Board on March 24, 2026; offer letter amends and restates prior Consulting Agreement dated January 1, 2018.
• ·Amended and Restated Change in Control and Severance Agreement dated November 10, 2025 remains in full force.
• ·Base salary payable semi-monthly based on minimum 30 hours worked per week.
• ·Equity awards subject to 2021 Omnibus Equity Incentive Plan (or successor) with vesting tied to continued service.

27-03-2026

At the 2026 Annual Meeting on March 25, 2026, Concentrix Corporation shareholders elected all nine director nominees with strong support, ranging from 51,525,159 to 52,102,002 'For' votes each, amid 211,159 to 788,002 'Withhold' votes. Stockholders ratified Ernst & Young LLP as auditors for fiscal 2026 with 56,049,937 'For' votes versus 453,129 'Against', approved named executive officer compensation on an advisory basis with 50,867,486 'For' versus 1,372,520 'Against', and approved an amendment to the 2020 Stock Incentive Plan adding 3,700,000 shares with 36,462,977 'For' versus a notable 15,803,365 'Against'. Broker non-votes totaled 4,290,089 across director and compensation proposals.

• ·All nine directors received between 51,525,159 and 52,102,002 'For' votes, with 'Withhold' votes ranging from 211,159 to 788,002.
• ·Advisory vote on executive compensation: 50,867,486 For, 1,372,520 Against, 73,155 Abstain.
• ·Auditor ratification abstain votes: 100,184.
• ·Plan amendment abstain votes: 46,819.

27-03-2026

On March 24, 2026, Sanjay Mehrotra informed CDW Corporation that he will not stand for reelection at the company's 2026 Annual Meeting of Stockholders. Mr. Mehrotra will continue to serve through the remainder of his current term. His decision was not related to any disagreement with the company on any matter relating to its operations, policies, or practices.

• ·Filing date: March 27, 2026
• ·Date of earliest event reported: March 24, 2026

27-03-2026

Four directors—David M. Abrams, Harry C. Curtis, Stella David, and Mary E. Landry—resigned from the boards of NCL Corporation Ltd. (NCLC) and parent Norwegian Cruise Line Holdings Ltd. (NCLH) effective March 31, 2026, with no disagreements on operations, policies, or practices. Five new independent directors—Stephen Pagliuca, Jonathan Cohen, Alex Cruz, Brian MacDonald, and Kevin Lansberry—were appointed to both boards effective the same date under a Cooperation Agreement with Elliott Investment Management entities, expanding the board from 8 to 9 members. New directors receive $100,000 annual cash retainer, $200,000 RSU award, and additional committee retainers, with no related party transactions disclosed.

• ·Jonathan Cohen and Alex Cruz appointed to Audit Committee alongside José E. Cil (Chair) and Zillah Byng-Thorne.
• ·Resignations and appointments announced March 26, 2026; effective March 31, 2026.
• ·New directors determined independent under SEC and NYSE rules; no arrangements beyond Cooperation Agreement.

27-03-2026

JAKKS Pacific, Inc. disclosed the establishment by its Compensation Committee of performance criteria for the 2026 Annual Performance Bonuses of President and CEO Stephen G. Berman and CFO John L. Kimble, based on tiered EBITDA targets starting above $35,587,507 and reaching a maximum above $65,587,507. Berman's base salary is $1,875,000 with a maximum bonus of 300% ($5,625,000), while Kimble's is $632,700 with a maximum of 200% ($1,265,400). Bonuses scale linearly between tiers: 25% for EBITDA >$35.6M to <$45.6M, up to maximum percentages at higher thresholds; adjustments possible for extraordinary items.

• ·EBITDA calculated before bonuses and one-time non-recurring costs for Board-approved initiatives.
• ·Compensation Committee retains discretion to adjust criteria for extraordinary items, strategic transaction fees, or economic conditions.
• ·Event date: March 25, 2026; Filing date: March 27, 2026.

27-03-2026

Sturm, Ruger & Company, Inc. (NYSE: RGR) appointed Andrew Wieland as Senior Vice President and Chief Financial Officer, succeeding Tom Dineen in a planned transition, with Dineen stepping down on March 31, 2026, and remaining until April 30, 2026. Wieland brings extensive financial leadership from Eaton Corporation, including roles in forecasting, planning, and finance transformation. The move supports Ruger's 2030 plan and long-term priorities under President & CEO Todd Seyfert.

• ·Tom Dineen began with Ruger in 1997, served as CFO since 2003, and as Vice President, CFO and Treasurer since 2006.
• ·Wieland previously served as Vice President of Finance and Controller of Eaton Electrical Sector Americas: Assemblies and Residential Solutions Group.

27-03-2026

Fuel Tech, Inc. announced its 2026 Corporate Incentive Plan (CIP), effective January 1, 2026, which provides annual cash bonuses to eligible U.S., European, and Canadian employees based on company Operating Income and individual performance, superseding prior bonus programs. No payouts occur unless Operating Income reaches a $250,000 threshold, with the incentive pool funded at 25% of Operating Income thereafter, capped at $3 million. Payouts are calculated using a formula incorporating base wages, target bonus factors, and realization percentages, with executives automatically at 100%.

• ·Eligible Employees exclude Sales Group members and those with separate ineligibility agreements; must be employed on December 31, 2026, for full payout eligibility (pro-rata for involuntary termination not for cause, death, or Disability).
• ·Individual Objectives communicated by April 15, 2026; Target Bonus Factors also by April 15, 2026.
• ·Plan administered by Compensation Committee with full discretion to amend or cancel at any time.
• ·Operating Income defined before impact of incentive pay but including sales commissions.

27-03-2026

Cue Biopharma, Inc. announced the resignation of President and CEO Usman Azam and his departure from the Board, effective March 26, 2026, ahead of the April 13, 2026 Annual Meeting. Lucinda Warren, current Chief Financial and Business Officer, was appointed Interim President and CEO effective March 27, 2026, while continuing in her prior role. The company entered into amended employment terms for Warren and a separation agreement for Azam, including severance payments.

• ·Lucinda Warren, age 57, has over 30 years of experience in pharmaceutical and biotechnology sectors.
• ·Usman Azam separation includes up to 12 months COBRA premium payments.
• ·Lucinda Warren severance entitlement: 9 months base salary plus prorated target bonus, up to 3 months COBRA.
• ·Agreements to be filed as exhibits to Q1 2026 10-Q.
• ·Company 2025 Stock Incentive Plan referenced for Warren option.

27-03-2026

Zeo ScientifiX, Inc. (ZEOX) terminated the employment of Dr. John D. Kisiday, Ph.D. as its Chief Science Officer, effective March 23, 2026. The 8-K filing was submitted on March 27, 2026, under Item 5.02. No details on the reasons for termination or any replacement were disclosed.

• ·Registrant details: Nevada incorporation, Commission File Number 000-55008, IRS EIN 47-4180540
• ·Principal executive offices: 3321 College Avenue, Suite 246, Davie, Florida 33314
• ·Telephone: (888) 963-7881

27-03-2026

Cyril A. Wallace, Jr. resigned as Chief Executive Officer, principal executive officer, and Director of Reed’s, Inc., effective March 24, 2026, with no disagreement on company matters; he will remain an employee until March 31, 2026. Neal M. Cohane, the current Chief Operating Officer, was appointed as Interim Chief Executive Officer, principal executive officer, and Director on the same date, to serve until the 2026 annual stockholder meeting. Cohane, age 65, brings prior experience as Chief Sales Officer at the Company and roles at Eastroc Beverage, Rootstock Brands, PepsiCo, SoBe, and Coca-Cola.

• ·Mr. Wallace notified the Board of his resignation on March 23, 2026.
• ·Appointment of Mr. Cohane recommended by the Nominating and Corporate Governance Committee.
• ·No arrangements, understandings, family relationships, or related party transactions involving Mr. Cohane.
• ·Common stock: $0.0001 par value per share, trading as REED on NYSE American LLC.

27-03-2026

Genesco Inc. reported that Cassandra E. Harris ceased serving as principal accounting officer effective March 25, 2026, after supporting the company via a Consulting Agreement through the fiscal 2026 Form 10-K filing. Mimi E. Vaughn, the company's President, CEO, and Interim CFO, was appointed principal accounting officer on March 26, 2026, until a successor is named, with no additional compensation or changes to her severance arrangements. This appointment ensures continuity with the existing financial leadership team.

• ·Ms. Harris' consulting role began March 7, 2026, following announcement on January 29, 2026.
• ·Ms. Vaughn has no family relationships with any director or executive officer.
• ·Ms. Vaughn has no direct or indirect material interest in any transaction under Item 404(a) of Regulation S-K.
• ·Biographical information for Ms. Vaughn incorporated by reference from fiscal year 2026 Form 10-K.

27-03-2026

On March 23, 2026, Dr. Jonathan Goldman and Mitchell Chan, members of the board of directors of Avalo Therapeutics, Inc., notified the company they will not stand for re-election at the 2026 Annual Meeting of Stockholders, and will continue serving until that meeting. Their decisions are not due to any disagreement with the company's operations, policies, or practices. The board thanked them for their service and contributions.

27-03-2026

On March 23, 2026, the Compensation Committee of Pro-Dex, Inc. approved a base salary increase for Chief Financial Officer Alisha K. Charlton from $247,200 to $257,000 per year, effective the next bi-weekly pay period. This adjustment represents approximately a 4% increase, with all other employment terms remaining unchanged on an at-will basis. The filing was made on March 27, 2026.

• ·Company address: 2361 McGaw Avenue, Irvine, California 92614
• ·Registrant’s telephone number: (949) 769-3200
• ·Securities: Common Stock, no par value (PDEX) on NASDAQ Capital Market

27-03-2026

Core & Main announced board and leadership changes effective April 1, 2026, as part of long-term succession planning, appointing M. Susan Hardwick, former CEO of American Water Works, as a director and talent and compensation committee member. Stephen LeClair retired from his roles as executive chair and board chair, with James Castellano appointed as the new board chair, James Hope as audit committee chair, and Robert Buck added to the audit committee. These changes position Ms. Hardwick as the ninth independent director on the ten-member board.

• ·Changes effective April 1, 2026.
• ·Stephen LeClair served as CEO from 2017 through March 2025 and board chair since 2024.
• ·Company focuses on municipal, non-residential, and residential end markets in US and Canada.

27-03-2026

Addentax Group Corp.'s Compensation Committee approved awards of 1,000,000 fully vested shares of common stock to Chief Operating Officer Wu Rui and 183,335 shares to President, CEO, Secretary, and Director Hong Zhida under the 2024 Equity Incentive Plan, with a grant date expected on April 8, 2026. The number of shares will be proportionately adjusted for the company's 1-for-15 reverse stock split effective March 30, 2026. These grants recognize the executives' services as part of the overall compensation program.

• ·Awards subject to terms of the 2024 Equity Incentive Plan and Share Award Agreement (Exhibit 10.1)
• ·1-for-15 reverse stock split expected effective March 30, 2026 (previously reported in 8-K filed March 26, 2026)
• ·Common stock par value $0.001 per share, traded on Nasdaq Capital Market (ATXG)

27-03-2026

Professor Sanjay Sarma resigned as a director of Rekor Systems, Inc. effective March 25, 2026, with no disagreements on company matters, and will continue supporting technology initiatives as Chairman of Rekor Labs, LLC. The company entered an amended employment agreement with CEO Robert A. Berman effective March 20, 2026, including a $395,000 base salary and 1,000,000 fully vested common stock shares, and a new agreement with CFO Joseph Nalepa effective November 17, 2025, with a $260,000 base salary and potential bonuses up to $75,000 initially and $150,000 target thereafter. Both agreements run through June 30, 2028, with 12-month severance provisions and enhanced change-in-control payments (3x base for Berman, 2x for Nalepa).

• ·Berman Agreement allows termination with 30 days' notice; immediate for Cause.
• ·Nalepa required to give 30 days' notice, at least 60 days before SEC filing deadlines.
• ·Agreements filed as Exhibits 10.1 (Berman) and 10.2 (Nalepa).

27-03-2026

SBA Communications Corporation announced that Mark Ciarfella, Executive Vice President, U.S. Operations, provided notice on March 24, 2026, of his intent to retire from his current roles effective December 31, 2026, and will remain as a non-executive employee until March 7, 2027, to support the transition. The filing was made on March 27, 2026, under Item 5.02. No successor has been named in the filing.

• ·Company headquartered at 8051 Congress Avenue, Boca Raton, FL 33487.
• ·Class A Common Stock ($0.01 par value) trades as SBAC on NASDAQ Global Select Market.

27-03-2026

On March 24, 2026, Ethan Chernin departed from Ardent Health, Inc. as President, Hospital Services, effective immediately. The Company classified the departure as a Qualifying Termination under its Executive Severance Plan, entitling him to severance and related benefits subject to plan terms and conditions.

• ·Severance details described in proxy statement for 2025 Annual Meeting filed April 8, 2025 (Schedule 14A)
• ·Severance Plan filed as exhibit to Form 10-Q for three months ended June 30, 2024, filed August 14, 2024
• ·Form 8-K filed March 27, 2026, reporting event of March 24, 2026

27-03-2026

Alessandro DiNello notified Flagstar Bank on March 25, 2026, of his decision not to stand for re-election at the 2026 Annual Meeting on June 9, 2026, with his term ending at the meeting's conclusion and no disagreements cited. Eli H. Miller was appointed to the Board effective April 1, 2026, to fill the vacancy from Brian Callanan's prior resignation, pursuant to the March 7, 2024 Investment Agreement with Liberty 77 Capital L.P. funds; Mr. Miller will serve on the Risk Assessment Committee and Technology and Operations Committee and receive standard non-employee director pay of $97,500 annual cash retainer and $130,000 annual equity award.

• ·Eli H. Miller's professional background: Senior Managing Director at Liberty Strategic Capital (leadership, fundraising, investments); Managing Director of Government Relations at Blackstone Inc. (April 2019-April 2021); Chief of Staff at U.S. Department of the Treasury (February 2017-April 2019).
• ·No material plan, contract, or arrangement entered or amended in connection with Mr. Miller’s appointment; no Item 404(a) transactions.
• ·Mr. Miller's term expires at the conclusion of the 2026 Annual Meeting.

27-03-2026

On March 23, 2026, the Compensation and Talent Committee of MiniMed Group, Inc. approved the MiniMed Severance Pay Plan for Executives and the MiniMed Group, Inc. Change of Control Severance Plan, applicable to named executive officers and certain executives at Vice President level and above. The Severance Plan provides lump-sum cash severance of two times annual base salary plus target annual bonus, plus 24 months of COBRA coverage, upon eligible termination not related to a change of control. The COC Severance Plan offers enhanced protections post-change of control, including three times base salary plus highest annual bonus, pro-rated bonus, extended retirement benefits, and three years of health/life insurance continuation.

• ·Severance benefits require execution and non-revocation of a release of claims and satisfaction of applicable conditions.
• ·COC Severance Plan guarantees continued employment on no less favorable terms for three years post-change of control.
• ·COC Plan includes 'better of' provision for Section 4999 excise tax: reduce payments to avoid tax or pay in full subject to tax.
• ·Full texts of plans to be filed as exhibits to Form 10-K for fiscal year ending April 24, 2026.
• ·Named executive officers are participants in both plans; equity vesting generally not continued under Severance Plan except for retirement-eligible executives.

27-03-2026

On March 26, 2026, Abdurazak Mudesir notified the Board of Directors of T-Mobile US, Inc. of his decision to resign from the Board and from the Nominating, Corporate Governance and Compliance Committee, effective March 31, 2026. Mr. Mudesir’s resignation is not the result of any disagreement with the Company on matters relating to operations, policies, or practices. The 8-K filing was signed by Peter Osvaldik, Chief Financial Officer, on March 27, 2026.

27-03-2026

Horace Mann Educators Corporation announced that Maureen Temchuk, Vice President, Controller and Chief Accounting Officer, will commence temporary maternity leave on or about March 30, 2026, expected to last until approximately July 6, 2026. Ryan Greenier, Executive Vice President and Chief Financial Officer, will serve as Interim Chief Accounting Officer during her absence, with no changes to his current compensation. The company expects Temchuk to resume her role upon completion of her leave.

• ·Ryan Greenier, age 44, has served as Executive Vice President and Chief Financial Officer since 2024; previously held roles including Deputy CFO, Chief Investment Officer, and others at Horace Mann.
• ·Prior to Horace Mann, Ryan Greenier held leadership roles at The Hartford and began his career at Deloitte and Touche; holds BBA in Accounting from Pace University and MBA in Finance from University of Connecticut.
• ·There are no arrangements or understandings with Ryan Greenier regarding his interim role, and no related-party transactions under Item 404(a) of Regulation S-K.

27-03-2026

On March 24, 2026, Romin Nabiey submitted his resignation as Chief Accounting Officer of GoodRx Holdings, Inc., effective April 3, 2026, to pursue other opportunities. He will remain an employee through June 8, 2026, to support the transition of his responsibilities. The resignation was not due to any disagreement with the company on matters related to operations, policies, or practices.

• ·Filing signed by Christopher McGinnis on March 27, 2026

27-03-2026

On March 25, 2026, the Board of First Industrial Realty Trust, Inc. ratified the criteria for the 2026 Employee Bonus Plan, an incentive compensation pool for eligible employees including the CEO and senior executives. Awards are based on three categories—NAREIT FFO per share (55% weighting), same store NOI growth (30% weighting), and discretionary objectives (15% weighting)—with performance levels funding the pool at 0%, 25%, 50%, 75%, 100%, or 125% per category, though overall payouts are capped at 115%. The Compensation Committee may adjust metrics for non-recurring items.

• ·Payout levels for each category: 0%, 25%, 50%, 75%, 100%, or 125%, with linear interpolation between levels
• ·Compensation Committee discretion to adjust for non-recurring items, unbudgeted investments/dispositions, accounting changes, or extraordinary items

27-03-2026

On March 24, 2026, Bruce Rothstein, a director of Cactus, Inc., notified the company that he will not stand for re-election at the 2026 Annual Meeting of Stockholders, with no disagreement on operations, policies, or practices. The Board of Directors will decrease its size to 8 members effective immediately before the annual meeting. This is a routine governance change with no reported issues.

• ·Filing submitted on March 27, 2026
• ·Registrant incorporated in Delaware with IRS Employer Identification No. 35-2586106

27-03-2026

Rapid Micro Biosystems, Inc. announced the departure of Chief Operating Officer John Wilson effective April 10, 2026, to spend more time with family, with no disagreement on company matters. President and CEO Robert Spignesi will assume the principal operating officer role on the same date, with no new material arrangements. The company entered a Consulting Services and Separation Agreement with Wilson, including advisory services at $200 per hour (up to 20 hours/month until June 30, 2026) and extended stock option exercise period to March 31, 2027.

• ·Wilson's departure effective April 10, 2026; notified March 23, 2026.
• ·Consulting not to exceed 20 hours per month.
• ·Extension of post-termination vested stock options exercise period to March 31, 2027.
• ·Agreement includes limits on weekly volume of Class A common stock sales, pledges, or transfers (with exceptions).
• ·Separation benefits per July 8, 2021 Employment Agreement.

27-03-2026

On March 23, 2026, the Compensation Committee of Pulse Biosciences, Inc. awarded Chief Technology Officer Darrin R. Uecker 100,000 restricted stock units (RSUs) of common stock ($0.001 par value) in recognition of his leadership in atrial fibrillation product development efforts. The RSUs vest in full on the third anniversary of the grant date, subject to the terms of the grant agreement and the Company's Amended and Restated 2017 Equity Incentive Plan. No other changes in directors or officers were reported.

• ·Grant made under the Amended and Restated 2017 Equity Incentive Plan
• ·Common stock par value: $0.001 per share
• ·Filing signed by Paul A. LaViolette on March 27, 2026

27-03-2026

On March 26, 2026, the Compensation Committee of American States Water Company approved the 2026 Short-Term Incentive Program for key executive officers, offering target aggregate cash bonuses equal to 100% of base salary for CEO Robert J. Sprowls, 40.4% for Eva G. Tang and Paul J. Rowley, 48.5% for Christopher H. Connor, and 34.2% for Gladys M. Farrow. The program includes 80% objective performance-based bonuses and 20% discretionary bonuses based on individual performance assessments. Exhibits 10.1 and 10.2 detail the program and award agreement.

• ·Program applies to 2026 calendar year.
• ·Bonus payable based on attainment of specific performance targets for objective portion and subjective assessment for discretionary portion.

27-03-2026

On March 25, 2026, HA Sustainable Infrastructure Capital, Inc. adopted the Executive Protection Plan (Severance Plan) for its CEO and certain management employees, offering tiered severance benefits upon Qualifying Termination. Tier A (CEO) provides up to 3.0x annual base salary plus average bonus in lump sum during Change in Control, with Tier B at 2.0x and Tier C at 1.5x, alongside COBRA payments; non-Change in Control benefits are lower for Tiers B and C. The plan becomes effective May 1, 2026, subject to release of claims, covenants, and potential excise tax mitigation without gross-up.

• ·Qualifying Termination defined as termination without Cause (or Constructive Termination for Tiers A/B).
• ·Severance subject to execution/non-revocation of release and compliance with restrictive covenants.
• ·Benefits reduced if exceeding parachute payment threshold under IRC Section 4999 for greater after-tax benefit; no tax gross-up.
• ·Full plan text to be filed as exhibit to Form 10-Q for quarter ending March 31, 2026.

27-03-2026

Madison Square Garden Entertainment Corp. entered into a new employment agreement with existing Executive Vice President and Treasurer Philip D’Ambrosio, effective April 1, 2026, following expiration of his prior agreement. The agreement sets a minimum annual base salary of $750,000, target annual bonus of at least 100% of base salary, and expected annual long-term incentive awards with aggregate target value of at least $1,400,000. It outlines severance benefits, including discretionary payments no less than base plus target bonus plus prior and prorated bonuses upon qualifying terminations before March 31, 2029.

• ·Employment agreement dated March 24, 2026; scheduled expiration March 31, 2029.
• ·Severance upon voluntary termination with 90 days' notice: immediate full vesting of long-term cash awards, RSUs, and stock options.
• ·Noncompetition covenant restricts competitive activities until first anniversary of termination on or prior to March 31, 2029.

27-03-2026

On March 25, 2026, Sangjin Yeo submitted his resignation from the Board of Directors and Audit Committee of Exicure, Inc., effective March 27, 2026. The resignation did not result from any disagreement regarding the company's operations, policies, or practices. The 8-K filing was signed by Jung Soo Kim, Chief Executive Officer.

27-03-2026

On March 26, 2026, Nuwellis, Inc. directors Mika Grasso and Katharyn Field resigned effective immediately, citing disagreements with the company and its advisors over timely access to information, impairing their ability to fulfill duties. The company disputes these allegations as containing factual errors, misleading speculations, and malicious interpretations, and has filed their resignation letters as exhibits. As a result, the Board reduced its size from seven to five members effective March 27, 2026.

• ·Resignation letters filed as Exhibit 17.1 (Grasso) and 17.2 (Field).
• ·Company providing departing directors opportunity to respond, to be filed as amendment if received within two business days.
• ·Filing signed by John L. Erb on March 27, 2026.

27-03-2026

MaxCyte, Inc. (Nasdaq: MXCT) appointed Parmeet Ahuja as Chief Financial Officer effective March 30, 2026, succeeding Douglas Swirsky who is transitioning from the role as previously announced in November 2025. Ahuja brings over 20 years of finance leadership experience from Agilent Technologies, including roles in investor relations, operational finance, and financial planning. CEO Maher Masoud praised Ahuja's expertise to support the company's growth phase.

• ·Announcement date: March 23, 2026
• ·MaxCyte has been advancing cell engineering for more than 25 years
• ·Ahuja holds an MBA in Finance from San Jose State University and a Bachelor of Commerce in Accounting from Delhi University

27-03-2026

On March 27, 2026, Hyatt Hotels Corporation's Board of Directors increased its size from eleven to twelve members and appointed Gianni Marostica as a Class II director, effective immediately, to serve until the 2026 annual meeting of stockholders. There is no arrangement or understanding between Mr. Marostica and any other person regarding his appointment, and he has no direct or indirect material interest in any transaction requiring disclosure under Item 404(a) of Regulation S-K. Mr. Marostica will receive compensation on the same basis as other non-employee directors pursuant to the company's director compensation plans.

• ·Mr. Marostica appointed to hold office until the 2026 annual meeting of stockholders and until his successor is duly elected and qualified.
• ·Compensation governed by Hyatt Hotels Corporation Summary of Amended and Restated Non-Employee Director Compensation and the Amended and Restated Hyatt Hotels Corporation Deferred Compensation Plan for Directors.

27-03-2026

Genco Shipping & Trading Limited filed an 8-K on March 27, 2026, under Items 5.02 and 9.01, attaching as Exhibit 10.1 its Employee Retention Plan, previously disclosed in a Form 8-K on February 13, 2026. The filing incorporates the prior description by reference and was signed by Chief Financial Officer Peter Allen. No officer departures, elections, or new compensatory arrangements are detailed beyond the referenced plan.

27-03-2026

Telomir Pharmaceuticals, Inc. filed an 8-K on March 27, 2026, including Exhibit 3.1: Amended and Restated Bylaws, which outline corporate governance procedures such as principal offices, annual and special shareholder meetings, notice requirements (10-60 days prior), and remote communication options. The bylaws specify quorum as one-third of votes entitled to be cast, voting entitlements (one vote per share), and provisions for record dates and shareholder lists. This accompanies Items 5.02 (director/officer changes), 5.03 (bylaws amendment), 5.07, and 9.01, with no financial metrics or performance changes reported.

• ·Quorum for shareholder meetings requires one-third of votes entitled to be cast on the matter.
• ·Notice of shareholder meetings must be given 10-60 days in advance; special meeting notice within 60 days of demand.
• ·Record date for meetings cannot exceed 70 days prior to the meeting or precede the resolution fixing it.
• ·Shareholder lists must be available for inspection 10 days prior to meetings.

27-03-2026

Blink Charging Co. disclosed that Martha J. Crawford, Ph.D., a member of its Board of Directors and committees including Audit, Compensation, and Nominating and Corporate Governance, will not stand for re-election at the 2026 Annual Meeting of Stockholders and will continue serving until her term expires. The Board has initiated a process to identify and nominate a qualified replacement to fill the vacancy.

• ·Filing Date: March 27, 2026
• ·Date of Earliest Event Reported: March 23, 2026
• ·Securities Registered: Common Stock (BLNK) on The Nasdaq Stock Market LLC

27-03-2026

Amarin Corporation plc announced that Dr. Paul Cohen and Mr. Oliver O’Connor will not stand for re-election at the 2026 Annual Meeting of Shareholders, resulting in a reduction of the Board size from nine to seven directors effective immediately prior to the meeting; the decisions were not due to any disagreements on operations, policies, or practices. On March 25, 2026, the Board approved updates to the non-employee Director Compensation Policy, providing annual equity awards of Restricted Stock Units and Options vesting on the one-year anniversary of grant or the next annual general meeting. These equity awards are contingent on shareholder approval of issuance and pre-emption proposals at the 2026 Annual Meeting, with cash compensation as a potential alternative if not approved.

• ·Resignations notified to the Company on March 25, 2026.
• ·Initial equity awards upon appointment and annual awards for continuing non-employee directors under the updated policy.

27-03-2026

First Watch Restaurant Group, Inc. terminated the employment of Dan Jones, its Chief Operations Officer, on March 27, 2026, as part of a restructuring of its operations leadership structure. Post-separation, the Company's operations leadership will report directly to the President and Chief Executive Officer. The Company recognized Mr. Jones' substantial contributions during a transformational period.

27-03-2026

PAVmed Inc. held a special stockholder meeting on March 27, 2026, with approximately 54.1% of outstanding voting power present in person or by proxy. Stockholders approved three proposals: (1) issuance of common stock upon conversion of 60,000 shares of Series D Convertible Preferred Stock and related warrants from a February 3, 2026 private placement, and pursuant to an Amended and Restated Senior Secured Convertible Note; (2) amendment to the Certificate of Incorporation to allow removal of directors with or without cause; and (3) amendment to the 2014 Long-Term Incentive Equity Plan to add 1,500,000 shares, increasing total available shares to 1,713,517. All proposals received strong majority support with no broker non-votes.

• ·Certificate of Amendment to Certificate of Incorporation filed with Delaware Secretary of State on March 27, 2026, effective same date.
• ·Adjourn proposal not presented as other proposals were approved.
• ·Definitive Proxy Statement filed February 24, 2026; related Form 8-K filed February 4, 2026.

27-03-2026

On March 24, 2026, the Board of Directors of CareCloud, Inc. appointed Mr. Cameron Munter as a member of the Audit Committee, affirming his independence under Nasdaq Listing Rule 5605(c)(2). This brings the Audit Committee to three independent directors, enabling the Company to regain compliance with the rule. Nasdaq has issued notice confirming compliance.

• ·Securities: Common Stock (CCLD) and 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (CCLDO), both listed on Nasdaq Global Market
• ·Company address: 7 Clyde Road, Somerset, New Jersey 08873
• ·Filing signed by Norman Roth on March 27, 2026

27-03-2026

On March 24, 2026, BARK, Inc. announced that Chief Financial Officer Zahir Ibrahim will step down and separate from the company effective April 17, 2026, by mutual agreement with no disagreements on accounting principles, disclosures, or controls. Brian Dostie, the current Vice President of Accounting and Controller, will serve as Interim CFO and principal financial officer from that date. The company plans to conduct an external search for a permanent CFO.

• ·Mr. Ibrahim will receive severance payments and benefits under his Severance and Change in Control Agreement, as described in the February 12, 2026 Proxy Statement.
• ·No family relationships between Mr. Dostie and any director or executive officer; no arrangements or understandings pursuant to his selection.
• ·No transactions involving Mr. Dostie requiring disclosure under Item 404(a) of Regulation S-K.

27-03-2026

Charles & Colvard, Ltd. filed Articles of Amendment to its Bylaws, effective March 27, 2026, revising Article 3, Section 2 to state that the number of directors constituting the board shall be not less than three nor more than nine. The amendment was approved by the Board of Directors pursuant to the North Carolina Business Corporation Act and signed by Michael Levin, Executive Chair of the Board of Directors. No other changes to officer or director positions are detailed in the exhibit.

• ·Bylaws previously amended and restated effective May 19, 2011, and further amended effective January 20, 2025
• ·Amendment filed under Section 55-10-20 of the North Carolina Business Corporation Act
• ·SEC Filing Items: 5.02, 5.03, 9.01

27-03-2026

Norwegian Cruise Line Holdings Ltd. (NCLH) appointed John W. Chidsey as President and Chief Executive Officer on February 12, 2026, and entered into an employment agreement on March 26, 2026, providing an annual base salary of $1,715,000, a fixed fiscal 2026 bonus of $2.9 million, and a one-time front-loaded equity inducement award of 2,139,892 restricted share units valued at approximately $48 million (split into $28.8 million PSUs and $19.2 million RSUs). The PSUs cliff vest after four years based on absolute TSR CAGR targets (none if <5%, 50% at 5%, 100% at 10%, up to 200% at 20%+), with no additional equity grants planned until 2030. NCLH operates a fleet of 35 ships with nearly 75,000 berths and plans to add 16 ships (43,000 berths) through 2037.

• ·PSUs eligible for cliff vest after four-year period: 0% if TSR CAGR <5%, 50% at 5%, 100% at 10%, 200% at 20%+ (linear interpolation between).
• ·RSUs vest in four equal annual installments starting March 1, 2026 anniversaries.
• ·Equity granted outside Amended and Restated 2013 Performance Incentive Plan under NYSE inducement exemption.
• ·Employment agreement approved by Compensation Committee using same form as other senior executives.

27-03-2026

Steel Dynamics, Inc. (STLD) announced that long-serving directors Richard P. Teets, Jr. and Gabriel L. Shaheen will retire effective at the 2026 Annual Meeting of Shareholders on May 6, 2026. Teets, a co-founder with over 35 years of service, is commended for pioneering thin-slab-casting technology, shaping company culture, and providing industry leadership. Shaheen is thanked for over 16 years of financial acumen and strategic counsel.

• ·Press release dated March 27, 2026
• ·Teets highlighted for leadership in Steel Manufacturers Association and Association of Iron and Steel Technology
• ·Shaheen noted Steel Dynamics' growth in size, capability, and financial strength during his tenure